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Both the B cell receptor (BCR) and the T cell receptor (TCR) repertoires are generated
through essentially identical processes of V(D)J recombination, exonuclease trimming of
germline genes, and the random addition of non-template encoded nucleotides.The naïve
TCR repertoire is constrained by thymic selection, and TCR repertoire studies have there-
fore focused strongly on the diversity of MHC-binding complementarity determining region
(CDR) CDR3.The process of somatic point mutations has given B cell studies a major focus
on variable (IGHV, IGLV, and IGKV) genes.This in turn has influenced how both the naïve and
memory BCR repertoires have been studied. Diversity (D) genes are also more easily iden-
tified in BCR VDJ rearrangements than in TCR VDJ rearrangements, and this has allowed
the processes and elements that contribute to the incredible diversity of the immunoglob-
ulin heavy chain CDR3 to be analyzed in detail. This diversity can be contrasted with that
of the light chain where a small number of polypeptide sequences dominate the reper-
toire. Biases in the use of different germline genes, in gene processing, and in the addition
of non-template encoded nucleotides appear to be intrinsic to the recombination process,
imparting “shape” to the repertoire of rearranged genes as a result of differences spanning
many orders of magnitude in the probabilities that different BCRs will be generated. This
may function to increase the precursor frequency of naïve B cells with important specifici-
ties, and the likely emergence of such B cell lineages upon antigen exposure is discussed
with reference to public and private T cell clonotypes.
Keywords: BCR repertoire,TCR repertoire,V(D)J recombination, public clonotypes, private clonotypes, combinato-
rial diversity, junctional diversity
GERMLINE GENES AND LYMPHOCYTE DIVERSITY
The mammalian immune system has the ability to respond to
almost any antigen to which it is exposed because of the incred-
ible diversity of lymphocyte receptor molecules. The diversity of
both the B cell receptor (BCR) repertoire and the T cell receptor
(TCR) repertoire is made possible by multiple sets of highly similar
genes that recombine to form functional genes. Immunoglobu-
lin heavy chains are encoded by recombined VDJ genes that are
formed from sets of Variable (V), Diversity (D), and Joining (J)
genes (IGHV, IGHJ, IGHD), while VJ rearrangements of kappa
and lambda chain V genes (IGKV, IGLV) and J genes (IGKJ, IGLJ)
encode the immunoglobulin light chains (1, 2). TCR β-chains and
δ-chains are similarly encoded by distinct sets of V, D, and J genes
(TRBV, TRBD, TRBJ; TRDV, TRDD, TRDJ), while α-chains and
γ-chains are encoded by additional sets of V and J genes (TRAV,
TRAJ; TRGV, TRGJ) (3–5). The resulting combinatorial diver-
sity is expanded still further by junctional diversification arising
from exonuclease trimming of the recombining gene ends and
from the essentially random addition of nucleotides, between
the recombining genes, by the enzyme terminal deoxynucleotidyl
transferase (TdT) (6). Together, combinatorial diversity and junc-
tional diversity create the diversity of the naïve T cell and B cell
repertoires. Limitations to diversity may however be a feature of
V(D)J rearrangement that is as significant to immune function
as the bewildering number of lymphocyte specificities that can
theoretically be generated.
This review will present evidence that biases in the processes
that generate combinatorial and junctional diversity are such that
the probabilities of different BCRs and TCRs being generated is
highly variable. This results in B and T cells of some specifici-
ties being present within the naïve repertoire at high frequency,
while other specificities may or may not be present at all. The
unevenness of the receptor abundance distribution can be said to
give “shape” to the naïve B and T lymphocyte repertoires. This
distribution may be further shaped by processes including posi-
tive and negative selection, clonal expansion and, in the case of
immunoglobulin genes, by somatic hypermutation, however this
review will focus upon recombination and gene processing.
As the shape of the naïve human B and T cell lymphocyte reper-
toire is an outcome of the evolution of genetically determined
biases, this should ensure the presence of critical rearrangements
in the repertoire of all individuals. It should also ensure that these
critical rearrangements are carried by multiple naïve cells (see
Figure 1). Such populations of specific naïve lymphocytes will
have a competitive advantage during antigen-driven clonal selec-
tion, and any discussion of repertoire diversity that is limited to the
size of the population of unique receptors will therefore be ignor-
ing a parameter of likely biological significance. In this review, we
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FIGURE 1 |The receptor repertoire has “shape,” as biases and
constraints in the recombination process vary the probabilities of
generating particularV(D)J rearrangements. (A) Higher probability
rearrangements are generated through utilization of more frequently
rearranged gene segments. These segments are joined with minimal gene
processing and N-addition, increasing the chance of independent
rearrangements with identical or near identical CDR3s. (B) Lower probability
rearrangements utilize rarely rearranged germline gene segments and the
CDR3s are more diverse owing to increased nucleotide removals and
additions at the joins. (C)The many order of magnitude differences in the
likelihood of generating particular rearrangements shape the repertoire, with
higher probability rearrangements being frequently generated and as a
consequence being carried by many identical B-cells. Only a relatively small
number of unique rearrangements will be generated with probabilities high
enough to be carried by a large number of B cells, but this should ensure that
they are always present in the repertoire at significant levels. Conversely,
lower probability rearrangements may be so rare that they are carried only by
a single B cell, or are entirely absent from the repertoire. The lower probability
rearrangements that are carried by just one or at most a few B-cells likely
represent many millions of unique rearrangements.
will use the term “repertoire” to refer to the complete set of recep-
tors that are carried by an individual, including multiple copies
of particular sequences. The number of unique sequences that are
found within an individual’s repertoire will be described as the
“diversity” of the repertoire.
The size of the sets of germline genes make a major contri-
bution to lymphocyte diversity, but surprisingly, our knowledge
of these germline genes is far from complete. In part this is the
result of the complexity of the loci, for they feature numerous
highly similar genes that are thought to have evolved via gene
conversion (7), and duplication and divergence (8). These genes
are interspersed with many pseudogenes and repetitive elements
(8). Sequencing and annotation of the loci is therefore challeng-
ing. These complexities also mean that SNPs arising from short
read-length sequences generated in studies such as the HapMap
and 1000 Genomes projects, cannot be used for the imputation of
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full-length allelic variants. In fact, these projects utilize polyclonal
lymphoblastoid cells lines in which the immunoglobulin loci have
undergone somatic recombination, and the rearranged genes may
have been affected by somatic point mutation. This makes these
cell lines unsuited to the study of immunoglobulin genes (9).
Arguably, it is the BCR germline genes that are best known, and
paradoxically, this is because of their transformation through the
process of somatic hypermutation, during an immune response.
IGHV genes are by far the longest of the recombining IGH genes,
and they are the principal targets of the mutational machinery
(10, 11). Many studies of the immunogenetics of immunoglobulin
have therefore concentrated upon the IGHV genes. As it is neces-
sary to be certain of the germline origin of mutated sequences, if
accurate studies of point mutations are to be conducted, the com-
plete and accurate definition of the set of germline immunoglob-
ulin IGHV genes and allelic variants has been and should remain
a focus of research.
The official human IGHV germline gene dataset, curated by
the ImMunoGeneTics (IMGT) group, includes 129 functional
genes, open reading frames (ORF), and pseudogenes, as well as
over 200 allelic variants (12). Interest in these germline genes
has increased in recent years, resulting in 40 new allelic vari-
ants being reported since 2005 (13–17). Many additional IGHV
allelic variants have also been identified in recent high-throughput
sequencing studies, through analysis of cDNA-derived VDJ gene
rearrangements (18, 19), but these have not been accepted as part
of the official IGHV dataset. We have designated alleles identi-
fied in this way with unofficial allele names using an indicator
(“p”) of their “putative” nature (e.g., IGHV3-9∗p03) (15), and
these additional alleles can be found in the UNSWIg repertoire
(http://www.ihmmune.unsw.edu.au/unswig.php).
The official human light chain V gene datasets appear to be
relatively complete and accurate, though few allelic variants have
been reported (20). Nevertheless these few variants appear to be of
functional and clinical significance. For example, a variant kappa
gene allele was identified within the Navajo population and has
been reported to account for the susceptibility of this population
to infections (21).
The human IGH germline genes receive continuing attention
while the IMGT human TCR germline gene datasets have barely
changed since the complete sequences of the TCR gene loci were
first described (22, 23). The IMGT TRBV dataset includes 65 func-
tional genes, ORFs and pseudogenes, and just 13 allelic variants,
and no new TRBV sequence has been added to the dataset since
the publication of the complete sequence of the TRB locus in 1996
(22). Only three TRAV/TRDV sequences (24) in the IMGT dataset
are derived from studies published since the reporting of the com-
plete sequence of the TRAV/TRDV locus (23), and some variants
that were described soon afterward still remain officially unrecog-
nized (25). The incomplete nature of the IMGT TRBV, and TRAV
datasets in particular are clearly highlighted in the literature, for
sequencing studies have reported many SNPs in the coding regions
of these genes. Subramanyan and colleagues reported 279 SNPs
in a study of 63 TRBV genes in 10 individuals from each of four
human populations (26). Of these reported SNPs, 114 were located
in coding regions of functional TRBV genes (26). A similar study
of 57 TRAV/TRDV genes in the same 40 individuals resulted in the
discovery of 284 SNPs, 51 of which encode amino acid changes in
the coding regions of the gene sequences (27). The allelic variants
associated with these TRAV/TRDV and TRBV SNPs have not been
reported in the literature or in sequence databases, and they have
not been incorporated into the official gene datasets. This is sur-
prising because the SNPs were identified through amplification
and sequencing of full-length genomic sequences. It is also unfor-
tunate, for studies of TCR polymorphisms have shown that they
can be of functional significance (28, 29).
The BCR and TCR D loci contribute differently to the gen-
eration of diversity, and the differences in the nature of the loci
have influenced BCR and TCR research directions. The 27 human
IGHD genes include 25 functional genes, 23 of which are unique
(30). Although some IGHD genes, especially those of the IGHD1
gene family, are very similar, there is considerable sequence diver-
sity amongst the genes. The lengths of the IGHD genes vary
from 11 nucleotides to 37 nucleotides, and almost all of them
are substantially longer than the TRBD and TRDD genes. This
length and the IGHD gene variability have made improvement
in the identification of IGHD genes within VDJ rearrangements
a challenging but achievable research goal. Pursuit of this goal
has driven the development of immunoglobulin gene alignment
utilities including SODA2 (31), IgBLAST (32), and iHMMune-
align (33). The objective measurement of the performance of these
utilities is made difficult, however, by a lack of appropriate data
sets. Ideally, performance would be measured using rearranged
sequences of known composition. As such sets are unavailable,
clonally related sequences can be used (32, 33). We have also com-
pared the performance of different utilities using a set of long-read
pyrosequenced (Roche 454) IGH rearrangements from an indi-
vidual with a homozygous deletion of six IGHD genes (34). This
test measures performance by the number of VDJ rearrangements
in the dataset that are said to include the absent IGHD genes.
Together these studies demonstrate that IGHD genes can now be
identified with confidence, and as a consequence, analysis of the
BCR heavy chain complementarity determining region (CDR) 3
can include detailed analysis of IGHD gene usage, gene processing,
and N nucleotide addition.
Analysis of the TCR CDR3 is not so easy. The two human
TRBD genes are both short (12 and 16 nucleotides) and highly
similar at their 5′ ends (22). This makes their identification in VDJ
rearrangements particularly difficult. The TRBD genes within a
VDJ rearrangement are likely to be flanked by N-REGIONS of
non-template encoded nucleotides. These nucleotides are intro-
duced through the action of the TdT enzyme, which is biased to
the addition of guanine (G) nucleotides (35) and to the addition
of homopolymer tracts (36, 37). Distinguishing TRBD gene ends
from G-rich N nucleotides is difficult because the TRBD genes are
G-rich at both their 5′ and 3′ ends. A final complication is that the
two alleles of TRBD2 differ by just a single nucleotide. This critical
nucleotide is flanked on both sides, in both alleles, by GGG motifs.
For these reasons, few TCR studies have included detailed analy-
sis of TRBD genes and their processing, or of the N-REGIONS
that can only be defined after the identification of a TRBD gene
segment within the CDR3. Even the most recently developed TCR
alignment utility excludes identification of TRBD genes from its
output (38).

























































Jackson et al. Shaping the B cell repertoire
Analysis of the VDJ junction in TRD rearrangements is equally
difficult. The three human TRDD genes are just 8, 9, and 13
nucleotides in length (4). This makes their reliable identification
within VDJ rearrangements especially problematic if nucleotides
have been lost through exonuclease activity. Application of an
approach previously used in the analysis of BCR sequences (37)
suggests that eight nucleotides is the minimum D gene length
that will allow TRDD genes to be reliably distinguished from N-
REGIONS within a junction of 12 or fewer nucleotides, while 9
nucleotides are needed for regions from 13 to 15 nucleotides and
10 nucleotides for junctions greater than 15 nucleotides (Jackson,
unpublished data). It is therefore no surprise that few studies have
reported the partitioning of TRD junctions as two of the three
TRDD genes can only be confidently delineated from N-additions
in their unprocessed form.
The J loci of the human BCR and TCR also include important
differences. The IGHJ locus includes six functional genes, which
are all found downstream of the IGHD locus in a single clus-
ter. Allelic variants have been reported for IGHJ3, IGHJ4, IGHJ5,
and IGHJ6, though there is reason to doubt the existence of the
reported allelic variants of IGHJ3 and IGHJ5 (39). TCR J genes are
more numerous and are differently organized. The TRBJ genes are
found as a block of six genes located downstream from the TRDB1
gene, and a block of seven genes located downstream from the
TRDB2 gene. The TRDB1 gene can pair with all J genes, but the
TRDB2 gene is strongly biased toward pairing with its associated
J genes (40). There are also four functional J genes in the TRDJ
locus. Functional allelic variants have only been reported for the
TRBJ1-6 gene.
BIASES IN COMBINATORIAL DIVERSITY AND THE SHAPING
OF THE REPERTOIRE
Combinatorial diversity is that part of repertoire diversity that
results from the fact that functional receptor genes form by the
recombination of members of the sets of germline V, D, and J
genes. This diversity is usually calculated by simply multiplying
together the number of functional V, D, and J genes that are avail-
able within the genome. Such calculations, however, may promote
misunderstandings, for they encourage the view that “all genes are
equal,” and that all combinations are equally likely. TCR studies
have paid considerable attention to capturing an unbiased sam-
pling of the repertoire, for example using 5′ RACE to amplify TCR
transcripts from the constant region gene. Such studies have shown
that TCR genes are highly biased in their usage (41–43). In con-
trast, many BCR repertoire studies have amplified both mRNA and
genomic rearrangements, often using IGHV gene family-targeting
primer sets that were developed for the detection of malignan-
cies rather than for the investigation of the repertoire (44, 45).
Such primers almost certainly lead to some distortions in the rela-
tive abundances of different sequences that are seen. Nevertheless,
BCR studies utilizing different primer sets, and amplifying dif-
ferent source material are surprisingly consistent, and the B cell
literature provides unequivocal evidence of strong gene utilization
biases.
Different IGHV genes are used at frequencies that range from
as little as 0.1% to more than 10% of all rearrangements in an
individual’s naïve B cell repertoire (18, 46). Utilization frequencies
also vary between alleles. For example, analysis of VDJ recombina-
tion in different individuals has shown that IGHV1-2∗02 is used
approximately three times as often as IGHV1-2∗04, in individuals
who carry both these alleles (18). IGHV utilization frequencies are
surprisingly constant between individuals (47). Examples of such
consistency include IGHV1-46 which varies from 2 to 3.1% in dif-
ferent individuals (average 2.65%), IGHV3-21 which varies from
3.5 to 6.3% (average 4.59%), and IGHV3-49 which varies from 0.8
to 1.3% (average 1.0%) (18). This is not true for all genes, with
different individuals utilizing IGHV1-69 at frequencies that range
from 3.1 to 9.1% (average 6.2%) (18). IGHV3-23, which is typi-
cally the most utilized IGHV gene, was seen on average in 6.7% of
all VDJ sequences, but its utilization frequency in one individual
was 13.7% (18).
Biased gene usage is not confined to the IGHV genes. IGHD
gene usage varies from less than 1% (IGHD4-4/11) to over 15%
(IGHD3-22) of total rearrangements. Biases in the resulting amino
acid sequences of the CDR3 junction are even greater. IGHD
segments can be utilized in all three reading frames, and each
IGHD gene is therefore able to encode three distinct amino acid
sequences. Analysis of IGH rearrangements in which the IGHJ
is out-of-frame, and which are therefore non-productive, shows
each IGHD gene rearranges at equal frequency in each of the three
RFs, however among productive rearrangements there is a strong
skewing of the utilization of each gene toward a dominant RF
(48). This dominance is constant between individuals, and the
preferred RF is gene family dependent. Analysis of in-frame and
out-of-frame IGH rearrangements sequenced using the Illumina
platform suggests that the underlying rearrangement processes
have no reading frame bias, but that bias emerges from stronger
negative selection of sequences in certain reading frames (48).
Such negative selection particularly focuses on non-productive
sequences that result from the presence of stop codons within
the junction region. These are seen when many IGHD genes are
translated in the non-dominant reading frame, and such genes
can only be utilized in those reading frames if the stop codons are
removed by exonuclease trimming. When analysis of IGHD usage
in the expressed repertoire factors in the three RFs, the IGHD gene
utilization frequencies span three orders of magnitude. There is
also considerable variation between the utilization frequencies of
IGHJ genes. The IGHJ4 gene is present in approximately 45–50%
of rearrangements, while IGHJ6 accounts for a further 20–25% of
VDJ rearrangements (49, 50). IGHJ1, on the other hand, is utilized
by only 1% of all rearrangements (39).
Biases in light chain gene usage are just as strong. For IGK
rearrangements, preferential inclusion of IGKV3-20 was noted
in early studies of the expressed IGK repertoire of both adults
and neonates (51–53), while single cell PCR (54) and bioinfor-
matics analysis of IGK rearrangements from sequence databases
showed IGKV3-15, IGKV3-11, IGKV1-5, IGKV2-30, and IGKV1-
30/IGKV1D-39 to also display preferential rearrangement (20).
These biases were confirmed again recently in a high-throughput
sequencing study which also highlighted similarities in usage
between individuals, including similarities between individuals
from geographically distant and ethnically distinct populations
(55). Under-utilization and over-utilization of the J gene segments
have been reported. IGKJ1 and IGKJ2 appear more frequently,
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while there is under-utilization of IGKJ3 and IGKJ5 (20, 53, 54).
This skewing of IGKJ usage toward the genes located 5′ in the IGKJ
locus is seen despite the necessity for selection of more 3′ IGKJ
genes during secondary IGK rearrangements (56, 57). A similar
bias toward 5′ IGKJ genes is also seen in the mouse, and modeling
of mouse light chain rearrangement supports the strong underly-
ing tendency toward the initial rearrangement of IGKJ1 or IGKJ2
(58). The IGLV usage is strongly skewed toward a limited number
of the functional V segments with 3 of the 30 IGLVs accounting
for more than 50% of expressed rearrangements, and with indi-
vidual IGLV segment frequencies ranging from 0.02 to 27% (59).
Only four of the seven IGLJ are considered functional (60). The
four IGLJ range from almost 55% utilization in the expressed B
cell repertoire for IGLJ7, to just 5.5% for IGLJ1 (61).
Although bias in the reading frame of the IGHD gene is the
result of selection, other biases appear to be intrinsic to the recom-
bination process, for when analysis is confined to non-productive
rearrangements which carry an out-of-frame J-REGION, pref-
erential gene usage is still seen (48). Such sequences are not
subject to positive or negative selection. The same biases have
been observed among transcripts generated from transgenic mice
that carry a human heavy chain mini-locus (62), while in NOD-
scid-IL2Rγ null mice that had been reconstituted with human
hematopoietic stem cells, typical patterns of biased usage were
seen amongst the expressed light chain genes (63). Recent studies
in monozygotic twins show that they share utilization frequencies
for both the heavy and light chain genes (46, 63), with corre-
lations in a similar range to replicate biological samples. When
one twin was investigated following lymphocyte ablation therapy,
the reconstituted repertoire showed the same utilization patterns
(46). Unrelated individuals did not share this degree of correla-
tion. The biases in utilization frequencies of different V, D, and
J genes therefore appear to be genetically determined, and when
acted upon by the recombination machinery, the biases in that
process give rise to an individual’s distinct repertoire. Repertoire
shape is therefore directly linked to the genotype of an individ-
ual’s immunoglobulin gene loci. This has become even clearer
since high-throughput sequencing has allowed analysis to focus
upon individual chromosomes.
The large datasets that are now being generated by high-
throughput sequencing from single individuals are facilitating
analysis of the processes that shape the repertoire, but each dataset
still represents a mixture of rearrangements from two indepen-
dently recombining chromosomes. The fact that V(D)J rearrange-
ment is an intra-chromosomal event, however, means that every
V(D)J gene rearrangement provides information about the associ-
ation of different genes on a chromosome. Any heterozygous locus
allows each chromosome to be associated with one or the other
allele at that gene locus, and large sets of V(D)J rearrangements
can be analyzed to determine all the V, D, and J genes that rearrange
on each chromosome. This allows the determination of inferred
haplotypes (see Figure 2).
In practice, the complete inference of V, D, and J gene haplo-
types by the analysis of V(D)J rearrangements is only likely to be
possible in the case of the IGH locus. Approximately 40% of indi-
viduals are heterozygous at the IGHJ6 locus, and the IGHJ6 gene is
present in nearly 25% of all rearrangements. It therefore provides
FIGURE 2 | Inference of IGH haplotypes fromVDJ rearrangements. The
availability of large datasets of VDJ rearrangements from single individuals
permit the inference of all germline V, D, and J genes within the genome,
from analysis of apparent gene utilization within a dataset. As IGH VDJ
rearrangement is an intra-chromosomal event, gene pairing in VDJ
rearrangements can be used to infer which gene segments are carried by
the same chromosome. Leveraging the heterozygous IGHJ6 or IGHJ4 locus
allows the reconstruction of IGH gene segments on each chromosome and
for the IGH haplotype to be inferred.
an ideal “anchor-point” from which to haplotype the IGH locus.
Using this approach, we recently investigated the IGH locus in
nine individuals, and showed that all 18 IGH variable region gene
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haplotypes were unique (19). In addition to allelic variants, many
IGHV and IGHD gene deletions and IGHV gene duplications were
evident. The definition of haplotypes in this way is allowing IGH
gene usage frequencies to be studied with unprecedented accuracy,
but unfortunately no locus as appropriate as the IGHJ6 anchor-
point exists amongst the light chain genes or amongst TCR genes.
Limited investigations in the past have highlighted TCR haplo-
typic variation in the human population (64, 65), but the extent
of variation within the IGH locus suggests that considerably more
TCR variation may await discovery.
Many factors have been explored to explain biases in chromo-
somal recombination patterns. Variations in enhancers (66) have
been implicated in biased murine TCR gene usage. Variations in
recombination signal sequences (RSS) also influence utilization
frequencies of both human BCR (67, 68) and TCR (69) genes. The
IGKV polymorphism that has been linked to increased susceptibil-
ity to Haemophilus influenzae in the Navajo population includes a
single nucleotide change in the heptamer sequence of the RSS, and
it reduces recombination by 4.5-fold relative to the common allelic
variant (21). The non-amer and heptamer sequences of the RSS are
separated by either a 12 or 23 base pair spacer. Spacers also show
sequence variation, and there has been debate about the impact
this has on recombination efficiency. While some studies did not
observe any impact when the regular spacer sequence was replaced
with runs of GC pairs (70),competition assays using extra chromo-
somal substrates suggest differences in spacer sequence can result
in differences in recombination efficiency that mirror differential
gene usage in the V(D)J repertoire (67, 68). However, RSS varia-
tion cannot explain all differences in allele utilization. The recent
re-sequencing of the complete IGH locus found that the IGHV-
associated RSS were the same as those earlier reported by Matsuda
(71) even where different alleles of the gene were present (17).
Some variation in the frequency with which particular gene
sequences are seen in the repertoire may be explained by copy-
number variations (CNV). The presence of CNV within the IG
variable gene locus was first determined using sequence-specific
RFLP analysis to determine gene copy-number (72), and the affect
of CNV on expression levels was investigated through the exam-
ination of the binding of an anti-idiotypic monoclonal antibody
(G6) to tonsillar IgD+B-cells (73). An examination of 35 indi-
viduals found that they carried between 0 and 4 copies of the
IGHV1-69 gene. Linear regression determined that for each allele
copy, approximately 3% of B-cells were G6 reactive. Individual
differences in the IGHV1-69 copy-number could therefore result
in the contribution that this single gene makes varying from being
totally absent (0 copies) to being present in as many as 12% of
rearrangements in individuals with four available copies.
Sequencing of single chromosomes of an individual’s IGH locus
has now demonstrated that insertions, deletions, and complex
events have altered the copy-number of IGHV genes, including the
IGHV1-69 and IGHV3-23 genes (17). The duplicate IGHV3-23
genes remain within the genome as absolutely identical sequences.
The presence of these and other CNVs has also been highlighted
in bioinformatic studies of immunoglobulin genotypes (18) and
haplotypes (19), where sequence data from single individuals
clearly demonstrated that some individuals had more than two
“alleles” of a single IGHV gene. Genes were also found to be
absent from the genome of some individuals. A limitation of these
bioinformatics studies was that gene duplications could only be
detected if two distinct “allelic variants” were carried on a single
chromosome.
In addition to the underlying biases in utilization of germline
genes, a final bias has been identified that affects the contribution
of recombination frequencies to repertoire diversity. For reasons
that are presently unclear, there appear to be pairing preferences
for some IGHD and IGHJ genes that increase the frequency of
particular IGHD-IGHJ pairs within the repertoire. Biases were
first observed in a small set of 59 non-productive rearrangements
(74). Later analysis of 6,500 IGH VDJ sequences collected from
public databases led to the observation that 5′ IGHD genes paired
with increased frequency to the most 3′ IGHJ (J5/J6) and with
decreased frequency to the 5′ IGHJ (J1–J4) (50). In contrast, 3′
IGHD tended to preferentially pair with 5′ IGHJ rather than 3′
IGHJ (50). This observation is also supported by analysis of very
large datasets generated by pyrosequencing of VDJ rearrangements
from three healthy subjects (75). Significantly more pairings were
seen of IGHD2-2 and IGHD3-3 with IGHJ6, and of IGHD3-22
and IGHJ3 than would be predicted from the frequencies of these
genes in the overall dataset (75).
The bias in D-J pairing also extends to the TCRB loci where
the application of HTS approaches to murine TCRB repertoires
has revealed a pattern of TRBD to TRBJ pairing that correlates to
the genomic distance between rearranged genes (40). The TRBV
and TRBJ gene usage in the mice was biased toward particular
genes, but the pairings of TRBV and TRBJ were independent.
The physical chromatin structure of the TRBD and TRBJ loci was
investigated using a biophysical model of the chromatin confor-
mation. The biases in TRBD to TRBJ pairing appeared to be better
explained by this mechanical model than previously proposed
genetic models based on RSSs (40). The model was also extended
to human TRBJ usage with favorable evidence that chromatin
conformation determines TRJB gene usage.
Biases in the pairing of heavy and light chains have also been
reported. The existence of forbidden or unfavorable pairings of
germline heavy and light chain genes was described in the early
literature (76). This was not supported by later studies (77, 78), nor
was it supported by a recent study that applied high-throughput
sequencing to generate thousands of linked heavy and light chain
genes (79).
BIASES IN JUNCTIONAL DIVERSITY AND THE SHAPING OF
THE REPERTOIRE
Both the naive B cell and T cell repertoires are limited in the
periphery by processes of selection. However T cell selection
within the thymus is a particularly rigorous process, and it leads
to dramatic differences between the potential and the observed
repertoire diversity. The idiosyncratic nature of TCR selection in a
human population with abundant MHC diversity also means that
analysis of the processes that contribute to TCR diversity will be
difficult using datasets comprising sequences from multiple indi-
viduals. Sufficiently large datasets from single individuals with a
specific MHC profile finally became available with the application
of high-throughput sequencing to repertoire studies. However,
the continuing difficulties involved with the identification of TCR
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D genes and hence the other constituent elements within the
TCR CDR3 still discourage analysis of the genetic elements and
processes that contribute to this region. It is therefore studies of
BCR genes that provide the clearest insights into the processes that
contribute palindromic P nucleotides and non-template encoded
N nucleotides to theV(D)J junction, and into the process of exonu-
clease trimming that depletes the ends of recombining genes. A
recent study of BCR CDR3 suggested that as a result of these
processes, the circulating B cell population in a typical adult
human includes 3–9× 106 unique heavy chain CDR3 (80).
Palindromic or P nucleotides are formed by the asymmet-
ric opening of hairpin loops that form at gene ends during the
rearrangement process (81). In the absence of exonuclease activ-
ity, the opening of the hairpins can add short, self-complementary
single stranded extensions into the junctions. P nucleotide addi-
tion was first recognized as a process that can contribute to TCR
CDR3 (82, 83), however the contributions of P nucleotides to
the BCR repertoire have been more precisely quantified (84, 85).
Similarly, it is recognized that N nucleotides make a major con-
tribution to the diversity of both the TCR and BCR repertoire
(86), but only BCR N-REGIONS have been subjected to detailed
analysis (37). Where BCR studies have investigated the kinds of
amino acids that are likely within N-REGIONS, studies of TCR
N-REGIONS have focused upon analysis of the overall contribu-
tion of N-REGIONS to αβ TCR diversity. This has been studied in
a comparison of wild-type mice with mice carrying homozygous
null alleles for TdT (86). N-addition was estimated to contribute
to 90% of the diversity of the αβ TCR repertoire (86). Diversity
could be estimated in this and other studies because of the devel-
opment of “spectratyping” techniques, which is the analysis of the
CDR3 length distribution in PCR amplicons. It permitted some
of the first explorations of the T cell repertoire, however it only
allowed detailed analysis of N-REGIONS if further sequencing
was undertaken. Until the advent of high-throughput sequencing,
such analysis was usually compromised by the restricted number
of sequences that could be generated from any individual, and by
the challenges associated with D gene identification.
Non-template encoded N-additions are intrinsically biased
owing to the preference of TdT toward the incorporation of G
nucleotides. This is manifested in G/C-rich additions when view-
ing the N-REGIONS of the coding strand, as additions may be
made to both the coding and non-coding strands during recom-
bination. This has been demonstrated through analysis of extra-
chromosomal substrates transfected into human cell lines (36),
as well as by analysis of human BCR (37) and TCR (87) VDJ
rearrangements. The G/C bias is coupled with an apparent inter-
dependence of the additions, which leads to the formation of
homopolymer tracts (36, 37, 87). Together these biases ensure that
the germline gene-encoded regions of the CDR3 are frequently
flanked by amino acids such as glycine, that are encoded by G-
rich codons (88). It has been proposed that the inclusion of small
amino acids such as glycine, which has only a single side chain,
promotes flexibility of the CDR3 loop (88).
Exonuclease trimming is perhaps the least understood process
that contributes to the BCR and TCR repertoires. The mechanisms
responsible for the loss of nucleotides from the coding ends of
the genes during rearrangement remains to be determined, but
a number of features of the process have been described, and
intrinsic biases have been identified. The extent of processing from
each gene end involved in a join (VD or DJ) is independent (87).
That is, we do not see more processing on one side of the join to
compensate for reduced processing of the gene on the other side.
The processing differs for V, D, and J genes and for gene families.
Removals may therefore be impacted by the sequence of the gene
ends. Sequences with high A/T content appear more susceptible
to nucleotide loss, while sequences with high G/C content appear
resistant to processing (36, 84, 89, 90). This bias is still seen after
controlling for the G/C bias of N-REGIONS.
The gene sequence ends that remain after exonuclease process-
ing provide a final bias that shapes the repertoire. The gene ends
are constrained by the genetic code, to favor the formation of
codons for a surprisingly limited number of amino acids. This is
best illustrated in the case of the many IGHD genes that have the
nucleotide sequence TAC at their 3′ end (see Figure 3). In the dom-
inant reading frame, these nucleotides encode tyrosine. Removal
of a single nucleotide creates a situation where only provision of
a T or C (from N-addition or from the 5′ end of the IGHJ gene)
will result in a functional sequence, for TAA and TAG are stop
codons. Addition of C returns the sequence to its original state,
while addition of T results in an alternative tyrosine codon. In this
and other cases, the nucleotide sequences of the gene ends limit
the diversity that results from exonuclease removals.
B CELL LINEAGES AND T CELL CLONOTYPES IN THE
ANTIGEN-SPECIFIC RESPONSE
Biases that we have described in immunoglobulin V, D, and J gene
usage mean that at least seven orders of magnitude separate the
probabilities that the most likely and the least likely combinations
of recombining genes will be generated in the bone marrow. Many
additional orders of magnitude separate the most likely from the
FIGURE 3 | Germline gene segment sequences constrain junctional
diversity. This is illustrated by processing of the codon TAC, which encodes
tyrosine as the most 3′ amino acid in the preferred reading frame of many
IGHD genes. A highly probable outcome of the VDJ rearrangement process
is the loss of a single nucleotide from the IGHD coding end. If this occurs,
the productive repertoire for these Ds is strongly skewed toward tyrosine,
as two of the four possible nucleotide replacement events generate stop
codons, and the other two ensure the maintenance of tyrosine. These
nucleotides may be sourced from either N-addition or from the 5′ end of an
IGHJ segment. The outcome of N-addition is depicted in the bottom panel.
N-additions are colored in orange and below each of the four possible
outcomes is shown the likelihood of the enzyme TdT adding each
nucleotide base.
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least likely heavy and light chain pairs. The least likely BCRs are
so unlikely to be generated in the bone marrow that they almost
certainly will never be seen in an individual’s lifetime. The most
likely BCRs, on the other hand, may be so readily generated that
they are always present within the repertoire at high copy number.
These high copy-number sequences are likely to utilize a relative
handful of the available germline genes, and to have been subject to
minimal processing. TdT adds, on average, around 6 nucleotides
between joining genes, and 30 or more nucleotides may occasion-
ally be added to the VD, DJ, and VJ junctions, but it is highly
likely that no more than two nucleotides will be added. Even long
heavy chain CDR3 are likely to be the result of long germline
sequences rather than the result of long N-REGIONS (47). Six or
more nucleotides may be removed from the 3′ end of the IGHV
gene, but most sequences lose no more than two or three IGHV
nucleotides, and many sequences lose no nucleotides at all.
Without the added diversity that comes from D genes, the kappa
and lambda repertoires are strongly shaped by biased gene usage
and minimal processing and the diversity of the repertoires is sur-
prisingly limited. The light chain repertoires are dominated by
a very small number of amino acid sequences, and this domi-
nance is so extreme that even in the days of Sanger sequencing,
identical light chain gene rearrangements were reported by sepa-
rate studies from independent laboratories (20). The theoretical
diversity of the kappa repertoire has been estimated to be as high
as 4× 1024 unique nucleotide sequences (91). However analysis
of kappa sequences generated from single individuals by high-
throughput sequencing suggest the repertoire may include less
than 104 unique amino acid sequences (55), and some of these
sequences may be seen in over 1% of all kappa-bearing BCR (55).
The diversity of the expressed lambda repertoire has recently been
shown to be similarly restricted (63).
Although the heavy chain repertoire has much greater diver-
sity then the light chain repertoire, repertoire shaping may be
sufficiently extreme that some heavy chain sequences, and even
some BCR will be present at high copy number in the reper-
toire of every individual. We are not aware of identical heavy
chain sequences being amplified from multiple individuals, but
highly similar “stereotypical” sequences have been found amongst
leukemic clones of individuals with chronic lymphocytic leukemia
(92). These stereotypical sequences differ through the stochas-
tic processes of somatic hypermutation, but they appear to have
evolved from cells expressing highly similar BCR within the naïve
B cell repertoires of different individuals. Antigen selection, which
may be associated with the pathogenesis of this condition (93),
could be selecting and therefore revealing high copy-number heavy
chain sequences.
The antigen specificity of most heavy and light chain sequences
remain unclear, for it is only very recently that antigen-specific
human B cells have been isolated and their BCRs investigated.
The isolation of antigen-specific plasmablasts from the peripheral
blood shortly after vaccination was first used to produce mon-
oclonal human antibodies (94). These cells express BCR genes
that are at once similar, as a consequence of their shared ori-
gins, yet highly divergent, as a result of the process of somatic
point mutation. Together they make up a B cell clone lineage.
High-throughput sequencing has since been used to identify clone
lineages after booster shots with the influenza vaccine (95) and
the pneumococcal vaccine (96). B cell lineages producing broadly
neutralizing antibodies to HIV have also been identified using
high-throughput sequencing (97). However this handful of stud-
ies of antigen-specific B cells in humans has not identified lin-
eages that are shared between individuals. Highly similar BCR
heavy chain sequences have recently been identified using high-
throughput sequencing of PBMC from multiple individuals with
acute symptomatic dengue (98). Although the specificities of these
sequences were not determined, such lineages were not identified
in uninfected individuals. These may therefore be the first antigen-
specific heavy chain “public lineages” to be identified. The extent
to which the response to specific antigen more generally involves
such “public lineages” remains to be determined.
In contrast to the paucity of studies of antigen-specific B cells,
antigen-specific TCRs have been investigated in the human reper-
toire for over 20 years. Early studies revealed that the immune
response to specific antigen, in HLA-matched individuals, can
include sets of T cells sharing identical or highly similar TCRα- and
β-chains (99–101). The development of techniques for the creation
of MHC peptide tetramer complexes has facilitated the identifi-
cation of antigen-specific T cells by flow cytometry (102). This
has allowed the detailed investigation of dominant sequence sets
and these studies gave rise to the notions of public and private T
cell “clonotypes.” Public clonotypes are defined as VDJ amino acid
sequences that are dominant and identical, or nearly identical, in
multiple individuals. Private clonotypes, in contrast, are idiosyn-
cratic. The apparently antigen-driven emergence of public B cell
lineages in chronic lymphocytic B cell leukemia also has parallels
amongst T cell leukemias. Studies of T cell large granular lympho-
cyte leukemias have identified a public clonotype in individuals
with the shared DRB1∗0701 HLA type (103). This same clono-
type was independently identified in DRB1∗0701+ individuals
who were infected with human cytomegalovirus (104), suggesting
that antigen-driven pathogenesis may be expanding and revealing
this public clonotype.
To understand the reasons for the emergence of particu-
lar clonotypes, the naïve repertoire must be better understood.
Enrichment techniques have recently been developed which
when combined with MHC peptide tetramer technology allows
extremely rare peptide-specific naïve murine T cells to be iden-
tified (105). Using this approach in humans, naïve CD8+ T cells
specific for peptide-MHC have been shown to range from 0.6 to
500 cells per million cells (106, 107) and CD4+ T cells to range
from 0.2 to 10 per million cells (107). Most of the cells within
identified sets of antigen-specific murine T cells express unique
TCRs (105), but clonal diversity within identified human cell pop-
ulations remains unclear. It is likely though that in the much larger
human T cell compartment, many circulating T cells could carry
identical TCRs. This should ensure that early adaptive responses
to these antigens are robust, for the strength of the response to
antigen has been shown to reflect the size of the antigen-specific
naïve T cell population (105).
The presence of particular public TCR clonotypes have not yet
been reported within the naïve human TCR repertoire. Discussion
of the emergence of such TCR clonotypes in an antigen-specific
response has therefore been driven principally by analyses of
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their nucleotide and amino acid features, and the phenomenon
of convergent recombination has been invoked to explain public
clonotypes (108, 109). Many public TCR clonotypes are diver-
gent at the nucleotide level, but identical at the amino acid level.
This results from the fact that particular amino acid sequences can
arise from multiple, variant nucleotide sequences, and that these
nucleotide sequences in turn can sometimes be formed by dif-
ferent genes with varying levels of gene processing and nucleotide
addition. Such convergent recombination will certainly contribute
to the presence of multiple copies of particular amino acid clono-
types within an individual’s repertoire, but arguably, it is unlikely
to increase the likelihood of one clonotype over another by more
than one or two orders of magnitude.
More recently the role of biases in gene usage and in the recom-
bination process have been identified as an alternative source of
public clonotypes (110). The biases in the usage of TCR V, D, and J
genes are less pronounced than is the case for the BCR genes. This
is the result of the lack of substantial germline diversity within the
sets of TRBD and TRDD genes, and because the TRBJ and TRDJ
genes lack the strong usage biases that are seen amongst the IGHJ
genes. Nevertheless biases in the usage of TCR genes are still likely
to ensure that the probabilities of the generation of the least likely
and the most likely V(D)J combination seen in αβ and γδ TCR dif-
fer by many orders of magnitude. It has also been pointed out that
many public clonotypes have short CDR3 loops that are mainly
encoded by germline-derived nucleotides rather then TdT-derived
nucleotides (110). The contribution this may make to the forma-
tion of T cell clonotypes is harder to judge, because of the lack
of detailed analysis of these processes, in the context of the TCR
repertoire. However lessons from analysis of the BCR repertoire
give strong credence to this hypothesis.
Both the BCR and the TCR repertoires have been the sub-
ject of considerable study and even greater speculation over many
decades. High-throughput sequencing is now revealing their sep-
arate secrets at a gratifying rate. Our understanding of the shaping
of the BCR and TCR repertoires will now surely move faster if a
greater dialog commences between researchers on the two sides
of the lymphocyte divide. BCR repertoire studies will be trans-
formed when greater attention is paid to antigen-specific lineages.
TCR repertoire studies, in turn, could benefit from the lessons of
the BCR repertoire, which suggest that the analysis of full-length
V(D)J rearrangements, and detailed analysis of the nucleotide
elements within the CDR3, can help explain the shaping of the
repertoire.
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